In the high-stakes world of product innovation, companies often face a paradox: adopting cutting-edge technology—such as biosensors that monitor heart rate and stress or energy-efficient chips that enable continuous health tracking in wearable devices—can make or break a product, but the methods used to evaluate these decisions are often outdated, treating new technology as a risk to be minimized rather than an opportunity to be seized.